Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crinos is an Italian pharmaceutical company founded in 1944, specializing in the research, development, and commercialization of treatments for cardiovascular and metabolic diseases. The company is historically significant for discovering and developing sulodexide and defibrotide, two complex biological drugs used globally for vascular and hematological conditions. In 1996, Crinos was acquired by Mediolanum Farmaceutici, under which it continues to operate as a prominent brand in the Italian healthcare market. Its current portfolio focuses on vascular health, gastroenterology, and specialized primary care products. The company maintains a strong presence in Italy while its legacy products are distributed internationally through various licensing partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crinos.